Patents Assigned to KNOZE JR. CORPORATION
-
Patent number: 11364217Abstract: A composition useful for promoting a desired oral microbiota to treat an allergy related respiratory condition in a subject in need of such treatment, the composition including an amino acid containing ingredient including individual molecules of L-arginine; the composition in a configuration to be maintained within the oral cavity for a period of at least about 30 seconds to about an hour, the desired oral microbiota including Veillonella and Streptococcus.Type: GrantFiled: September 15, 2017Date of Patent: June 21, 2022Assignee: Knoze Jr. CorporationInventor: Shunsheng Han
-
Publication number: 20210338747Abstract: A formulated oral prebiotic edible composition includes a free amino acid containing ingredient comprising L-arginine, the L-arginine comprising free individual molecules of L-arginine, the free individual molecules of L-arginine L present at a concentration of greater than about 0.1 weight percent, a carrier, and a sugar comprising at least one of a monosaccharide and disaccharide, at least two distinct live lactic acid probiotics, wherein one is a lactic acid producing bacterium, and one is a lactic acid fermenting bacterium, wherein the composition is in configuration suitable to be maintained substantively dissolved within the oral cavity, and wherein the composition is in an effective amount to selectively promote stimulation of a first oral microbiota to produce an excretion product, and wherein a second oral microbiota metabolizes the excretion product to treat the respiratory allergic condition and/or an oral and/or sinus infection.Type: ApplicationFiled: July 15, 2021Publication date: November 4, 2021Applicant: Knoze Jr. CorporationInventor: Shunsheng Han
-
Patent number: 11083760Abstract: A formulated oral prebiotic edible composition useful for promoting a desired oral microbiota to treat a respiratory allergic condition and/or an oral and/or sinus infection condition in a subject in need of such treatment, the oral prebiotic including comprising L-arginine, the L-arginine including free individual molecules of L-arginine, the free individual molecules of L-arginine L present at a concentration of greater than about 0.1 wt %; a carrier, and a sugar comprising at least one of a monosaccharide and disaccharide; the composition in a configuration suitable to be maintained including being substantially dissolved within the oral cavity for over a period of at least about 1 minute to about an hour, the composition in an effective amount to thereby selectively promote an increased concentration of oral microbiota to thereby treat the respiratory and/or oral and/or sinus related allergy condition, the selected oral microbiota including Veillonella and Streptococcus.Type: GrantFiled: July 23, 2019Date of Patent: August 10, 2021Assignee: Knoze Jr. CorporationInventor: Shunsheng Han
-
Patent number: 11083759Abstract: A method of selectively promoting a desired oral microbiota to treat an inflammation condition associated with an allergic reaction in a subject in need of such treatment including providing a composition including: at least one live bacterial population including lactic acid producing bacteria and lactic acid fermenting bacteria; and, an amino acid containing ingredient comprising L-arginine; at least partially removing a biofilm within an oral cavity of the subject; wherein the composition is contained within the oral cavity of the subject in an effective amount to selectively promote an increased concentration of selected oral microbiota comprising the lactic acid producing bacteria and the lactic acid fermenting bacteria to thereby treat the inflammation condition.Type: GrantFiled: July 8, 2019Date of Patent: August 10, 2021Assignee: Knoze Jr. CorporationInventor: Shunsheng Han
-
Patent number: 10471033Abstract: A method of promoting a desired oral microbiota to treat an inflammation condition related to an allergic reaction in a subject in need of such treatment including providing a preformulated edible composition including an amino acid containing ingredient comprising L-arginine, the composition configured to be present as individual molecules of L-arginine within an oral cavity of the subject; removing a biofilm from surfaces within an oral cavity including exposing the biofilm to a biofilm degrading enzyme; wherein during or following removal of the biofilm, the composition is provided contained and at least partially dissolved within an oral cavity of the subject for a period of at least from about 30 seconds to about an hour on a daily basis comprising at least one day to promote an increased concentration of selected oral microbiota, the selected microbiota including Veillonella and Streptococcus.Type: GrantFiled: June 6, 2018Date of Patent: November 12, 2019Assignee: Knoze Jr. CorporationInventor: Shunsheng Han
-
Patent number: 10398670Abstract: A method of promoting a desired oral microbiota to treat an oral and/or sinus infection condition in a subject in need of such treatment including providing a preformulated prebiotic edible composition including an amino acid containing ingredient comprising individual molecules of L-arginine; substantially removing a biofilm from surfaces within an oral cavity by heating the inside of the oral cavity to a temperature of about 100 deg F. to about 130 deg F.; wherein following removal of the biofilm, the composition is provided contained and at least partially dissolved within an oral cavity of the subject for a period of at least from about 30 seconds to about an hour on a daily basis of at least two consecutive days to promote an increased concentration of selected oral microbiota, the selected microbiota comprising Veillonella and Streptococcus, thereby treating the oral and/or sinus infection condition.Type: GrantFiled: September 15, 2017Date of Patent: September 3, 2019Assignee: Knoze Jr. CorporationInventor: Shunsheng Han
-
Patent number: 9795579Abstract: A method of promoting a desired oral microbiota in a subject to treat an allergy related respiratory condition, the method including providing an edible composition including an amino acid containing ingredient comprising L-arginine wherein the composition is provided contained and at least partially dissolved within an oral cavity of the subject for a period of at least from about 10 seconds to about an hour on a daily basis of at least two consecutive days.Type: GrantFiled: April 24, 2017Date of Patent: October 24, 2017Assignee: KNOZE JR. CORPORATIONInventor: Shunsheng Han